U.S. markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
275.94+0.34 (+0.12%)
Al cierre: 04:00PM EDT
276.89 +0.95 (+0.34%)
Fuera de horario: 05:59PM EDT

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo8,030

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Norman D. SchwartzChairman, CEO & President1.25M19.51M1950
Dr. Andrew J. Last Ph.D.Executive VP & COO682.29kN/D1960
Dr. Simon MayExecutive VP & President of the Life Science Group536.25kN/D1972
Mr. Roop K. LakkarajuExecutive VP & CFON/DN/D1971
Ms. Tania DeVilliersSenior Director, Corporate Controller & Interim Principal Accounting OfficerN/DN/D1974
Mr. Yong ChungVice President of Investor RelationsN/DN/DN/D
Mr. Timothy S. ErnstExecutive VP, General Counsel & SecretaryN/DN/D1960
Matthew WernerSenior Vice President and Chief Compliance & Privacy OfficerN/DN/DN/D
Ms. Colleen CoreyExecutive Vice President of Global Human ResourcesN/DN/D1962
Mr. Michael CrowleyExecutive Vice President of Global Commercial Operations974.94k1.85M1962
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Gestión corporativa

La calificación ISS Governance QuickScore de Bio-Rad Laboratories, Inc. a partir del 1 de abril de 2024 es 10. Las puntuaciones principales son Auditoría: 10; Junta: 10; Derechos del accionista: 10; Compensación: 8.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.